1. Home
  2. Author Blogs

Author: Adam Green

Adam Green

Adam is a writer and editor specialising in science, technology and public policy. As a regular contributor to the Financial Times special reports desk, he has covered topics including how big data can help cities prepare for disasters, the bioethics of gene therapy, and what the rise of quantum computers means for privacy and encryption. He also writes, edits and project manages technology and science-related research projects for The Economist Intelligence Unit, sister company to The Economist newspaper, working with organisations including Microsoft, Google, the Bill and Melinda Gates Foundation, and UNICEF.

LATEST ARTICLES

Well-Being
Building Estonia’s Biobank: How Government Can Power Medical Research

Building Estonia’s Biobank: How Government Can Power Medical Research

There are now over 100 biobanks worldwide, ranging from small university-based repositories to larger collections supported by governments. These collections of human biological samples, stored in cryogenic facilities could revolutionize medicine by giving researchers access

Governance
Biobanks: Why Governments Need to Step Up

Biobanks: Why Governments Need to Step Up

Biobanks -- collections of human biological samples, stored in cryogenic facilities -- could revolutionize medicine by giving researchers access to population-wide data through which they can study the interplay of genetics and disease. Governments are

Inclusive Economy
Leading the Way in Democratizing Data and Harnessing the Power of AI in Africa

Leading the Way in Democratizing Data and Harnessing the Power of AI in Africa

Governments across the world are grappling with the many ways in which artificial intelligence will change our societies. A digital divide already separates us. If these technologies are not harnessed wisely, they could be a

Inclusive Economy
Data Science Innovators Connect Talent and Governments

Data Science Innovators Connect Talent and Governments

Governments are realizing the power of data to tackle complex problems, but raw data is not enough to inform policy decisions. Analyzing and interpreting data requires deep expertise in modelling, statistics and data science. The

Education
Bell Tolls on Student Debt Reform

Bell Tolls on Student Debt Reform

A university education has been an engine of social mobility in the US for close to a century but spiraling student debt is risking a more unequal economy, as underprivileged students struggle to meet the

Citizenship & Rights
Nimble Governance: Estonia’s Digital Residency Reforms Reflect Start-Up Culture

Nimble Governance: Estonia’s Digital Residency Reforms Reflect Start-Up Culture

In December 2014, Edward Lucas, then an editor at The Economist, became Estonia’s first e-Resident. The initiative, hatched earlier that year, issues a digital identity to people outside the country, providing them access to e-governance

Citizenship & Rights
A Unique ID For Every Citizen: Q&A With Tariq Malik

A Unique ID For Every Citizen: Q&A With Tariq Malik

Official IDs are controversial. Libertarians often see them as an expression of a Big Brother state. Yet the lack of an official ID often in effect excludes disadvantaged citizens from participating fully in society. It

Health
Drugs And The City: How Vancouver Pushed Change

Drugs And The City: How Vancouver Pushed Change

A two-decade rise in drug addiction and overdoses, and HIV infections among drug users, culminated in Vancouver declaring a public health emergency in 1997. People from all walks of life were being touched by the

Health
From Warfare to Healthcare? Drugs Policy in the Americas

From Warfare to Healthcare? Drugs Policy in the Americas

The ‘drug war’ was born in the Americas. From the Nixon era onwards, the US government viewed drugs as a problem for the military abroad and the criminal justice system at home. Narcotics have been

Governance
Decriminalizing Drugs the Portuguese Way

Decriminalizing Drugs the Portuguese Way

As drug decriminalization spreads around the world, many policy makers are looking for inspiration to Portugal. In the past two decades the European nation has set the global benchmark for evidence-based drug reform. When Driving

Sign up for our newsletter